Treatment for Pulmonary Fibrosis in Philadelphia

Treatment for Pulmonary Fibrosis in Philadelphia

What is Pulmonary Fibrosis?

Pulmonary fibrosis is a disease in which the lungs become scarred, causing the intricate passageways inside the lungs to thicken and harden. Hardening of passageways inside the lungs makes it difficult for oxygen to pass through the walls of the tiny air sacs (alveoli) into the bloodstream. The lack of oxygen in the bloodstream leaves sufferers of pulmonary fibrosis short of breath even after periods of prolonged rest. Pulmonary fibrosis is a progressive disease in which sufferers get worse over time, sometimes slowly and other times rapidly. There are, however, new treatment options that help improve the quality of life for those who suffer from the disease. The Lung Institute offers treatment for pulmonary fibrosis in Philadelphia at our Pittsburgh clinic.

Quick Facts about Pulmonary Fibrosis:

  • It affects 200,000 people in the United States.
  • The average survival rate is two to three years.
  • There is no known cause for idiopathic pulmonary fibrosis.
  • About 48,000 new cases are diagnosed each year.
  • The disease tends to affect more men than women and typically occurs between ages 50 to 70
  • Pulmonary fibrosis is caused by occupational and environmental factors, a response from medications, autoimmune disorders, infections and genetics.

What is Stem Cell Therapy for Pulmonary Fibrosis?

Stem cell therapy harnesses the body’s natural healing capabilities to expedite the healing process. At the Lung Institute, the stem cell procedure is a three day outpatient treatment, where stem cells are extracted from a person’s blood, fat tissue or bone marrow. After the cells have been extracted, they are treated in a lab on site and then reintroduced into the body directly into the damaged tissue areas. Stem cells are how your body heals itself after getting a cut or bruise, however, sometimes this healing process can move more slowly than the disease progresses, like in the case of lung disease. By targeting many stem cells directly onto the damaged tissue, the body has the opportunity to heal itself more quickly. In most cases this results in stopping the progression of the disease or even improved lung function.

What Can You Expect?

The first step in the process with the Lung Institute is speaking with a patient coordinator, who will answer your questions and learn more about you and your condition. Once you decide that stem cell therapy is a good option for you, you will then receive a consultation either face to face or over the phone with your patient coordinator to determine the best treatment plan moving forward. You will then schedule your procedure at our clinic, which is a three day outpatient treatment. For those who suffer from lung disease in Philadelphia, the Pittsburgh clinic is the closest Lung Institute facility. This is a great opportunity to schedule a medical tourism trip to Pittsburgh for stem cell therapy. Finally, your patient coordinator will follow up with you after your treatment to keep close track of your recovery process.

At least 70 percent of Lung Institute patients have reported a better quality of life after undergoing stem cell treatment for pulmonary fibrosis. The Lung Institute might be the answer for those seeking treatment for pulmonary fibrosis in Pennsylvania. If you or a loved one suffers from a lung disease like COPD, contact one of our patient coordinators today at (800) 729-3065 to see if you qualify.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.